NGM BIOPHARMACEUTICALS INC's ticker is NGM and the CUSIP is 62921N105. A total of 96 filers reported holding NGM BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $626,580 | -58.7% | 585,589 | +0.0% | 0.00% | -50.0% |
| Q2 2023 | $1,516,406 | +114.4% | 585,485 | +237.7% | 0.00% | +100.0% |
| Q1 2023 | $707,423 | +70642.3% | 173,388 | +17338700.0% | 0.00% | – |
| Q4 2021 | $1,000 | -99.3% | 1 | -100.0% | 0.00% | – |
| Q3 2021 | $139,000 | +5.3% | 6,628 | -0.7% | 0.00% | – |
| Q2 2021 | $132,000 | +238.5% | 6,678 | +175.4% | 0.00% | – |
| Q3 2020 | $39,000 | -26.4% | 2,425 | -9.5% | 0.00% | – |
| Q2 2020 | $53,000 | +29.3% | 2,681 | -18.9% | 0.00% | – |
| Q1 2020 | $41,000 | -41.4% | 3,306 | -12.7% | 0.00% | – |
| Q4 2019 | $70,000 | – | 3,787 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenspring Associates, LLC | 1,573,357 | $47,665,000 | 61.89% |
| RHO CAPITAL PARTNERS INC | 3,766,666 | $114,111,000 | 60.06% |
| Column Group LLC | 15,396,116 | $466,502,000 | 42.31% |
| Ponoi II Management, LLC | 1,298,908 | $39,357,000 | 28.68% |
| Ponoi Management, LLC | 1,298,908 | $39,357,000 | 22.52% |
| Euclidean Capital LLC | 2,083,602 | $63,133,000 | 13.36% |
| Aquilo Capital Management, LLC | 1,005,534 | $30,463,000 | 6.33% |
| Octagon Capital Advisors LP | 75,227 | $2,279,000 | 0.79% |
| Jasper Ridge Partners, L.P. | 308,750 | $9,354,000 | 0.41% |
| Point72 Asset Management, L.P. | 1,761,157 | $53,354,000 | 0.26% |